Consumo de Substâncias e Função Cognitiva
Linas JuozėnasPartilhar
Legalidade não significa ausência de danos.
O álcool é uma substância psicoativa, tóxica e que causa dependência. A familiaridade, a legalidade e a publicidade podem fazê-lo parecer mais inofensivo do que é na realidade – mas o cérebro reage à substância química, à dose e à exposição, não ao seu estatuto social.
A comparação que a maioria das pessoas nunca vê
Numa análise de referência realizada por especialistas do Reino Unido, 20 substâncias psicoativas foram avaliadas segundo 16 critérios ponderados: danos físicos e psicológicos para o próprio consumidor, dependência, criminalidade, perturbação familiar, custos económicos e outros danos. O álcool obteve a pontuação global mais elevada.1
| Substância | Barra relativa | Pontuação total de danos em 100 |
|---|---|---|
| Álcool | 72 | |
| Heroína | 55 | |
| Cocaína crack | 54 | |
| Metanfetamina | 33 | |
| Cocaína | 27 | |
| Tabaco | 26 | |
| Anfetamina | 23 | |
| Canábis | 20 |
Como ler isto: são pontuações comparativas ponderadas, não percentagens nem uma escala de toxicidade que compare dose com dose. O resultado reflete o contexto do Reino Unido em 2010, os juízos de especialistas e os danos para os consumidores e para terceiros; alguns critérios eram relativos à população, mas as pontuações não constituem uma estimativa da carga total ajustada à prevalência. Isto não significa que uma bebida alcoólica seja, em termos agudos, mais perigosa do que uma dose de heroína, fentanil ou cocaína crack. Mostra por que razão a classificação legal e a familiaridade cultural não podem substituir uma avaliação dos danos baseada em evidências.
Porque é que o álcool sobe tanto na análise dos danos totais
Os comprimentos das barras usam a mesma escala de 72 pontos; componentes: álcool 26 + 46, heroína 34 + 21, cocaína crack 37 + 17. A heroína e a cocaína crack obtiveram pontuações mais elevadas relativamente aos danos para o próprio consumidor; a pontuação total excecionalmente elevada do álcool deveu-se aos danos muito maiores causados a terceiros.
Aiškus palyginimas žmones apsaugo geriau nei baimė ar kultūrinis įprotis
Alkoholis nėra už psichoaktyviųjų medžiagų kategorijos ribų. Etanolis keičia smegenų veiklą, gali sukelti toleranciją ir priklausomybę, blogina sprendimus bei atmintį ir priežastiniu ryšiu siejamas su ligomis, traumomis ir mirtimis. PSO jį tiesiai apibūdina kaip psichoaktyvią, toksišką ir priklausomybę sukeliančią medžiagą.3
Ši tiesa nereiškia, kad kiekviena nelegali medžiaga saugesnė. Nelegalus fentanilis ir heroinas gali turėti ypač didelę perdozavimo riziką; stimuliantai gali sukelti širdies ir kraujagyslių ar psichiatrines krizes; raminamosios medžiagos - pavojingą abstinenciją; o nereguliuojamuose produktuose gali būti medžiagų, kurių pirkėjas visai neketino vartoti. Skirtingos medžiagos dominuoja skirtingose žalos dimensijose.
Todėl sąžiningas klausimas nėra „Kurioje teisinės ribos pusėje tai yra?“ Klausimas toks: kokia medžiaga, kiek jos, kaip dažnai, kokiame amžiuje, su kuo kartu, kokiomis sąlygomis - ir kokios pasekmės žmogui bei visiems aplink jį?
“Harm” is not a single number
The ranking changes depending on the question. Good decisions begin by separating direct intoxication, poisoning risk, dependence, long-term illness and harm to other people.
Acute impairment
What happens during and after use: slower reactions, distorted confidence, poorer impulse control, memory impairment, anxiety, psychosis, unsafe driving, falls or violence.
Poisoning and overdose
How quickly breathing, body temperature, heart rate, blood pressure or consciousness can reach a life-threatening state. Fentanyl and other potent opioids are especially unforgiving here.
Dependence and withdrawal
How strongly repeated exposure recruits learning and reward systems, creates tolerance, narrows motivation and causes physical or psychological difficulties when use decreases.
Long-term and social harm
Cancer, cardiovascular or neurological diseases, lost learning opportunities, family disruption, poorer work, harm to others and social costs accumulate on a very different timescale.
A lower overall score never means “safe”
A substance may cause less total population harm because fewer people use it, yet be far more lethal at a particular dose or in a particular situation. Conversely, a widely available substance can cause enormous total harm even when most individual use episodes do not end in catastrophe. Population burden and the danger of one exposure answer different questions. In the Global Burden of Disease 2021 analysis, high alcohol consumption remained among the leading risk factors for years of healthy life lost in people aged 15–49.34
| Dimension | Ask | Why it changes the answer |
|---|---|---|
| Substance | What molecule or mixture is actually in the product? | Street names, product labels and legal categories can conceal potency, contaminants or entirely different active substances. |
| Dose and speed | How much substance reaches the brain and how quickly? | Rapid delivery and a sharp rise in concentration often increase intoxication, reward reinforcement and overdose risk. |
| Use pattern | Occasionally, often, in large episodic doses or continuously? | The same total amount can carry different risks when consumed over a short period or used without time to recover. |
| Person | Age, pregnancy, body, genes, medicines, mental and physical health? | Developing brains, illness, previous dependence and interacting medicines can change both effects and danger. |
| Context | Driving, water, height, conflict, isolation, access to help? | Many deaths and injuries arise from what happens when decision-making, balance or consciousness is altered. |
| Combination | What else was used - intentionally or unknowingly? | Effects can add up, multiply or mask one another. “I feel alert” does not mean “I am not intoxicated.” |
What psychoactive substances change in the brain
Psychoactive substances do not “add pleasure” or “switch off intelligence” through one chemical. They alter distributed systems that regulate salience, prediction, inhibition, memory, stress, movement and vital bodily functions.
Neurons communicate through electrical signals and chemical messengers. Psychoactive substances can mimic a neurotransmitter, block its reuptake, alter its release, act on a receptor or reorganise network responses. Dopamine matters for reward reinforcement and learning from outcomes; it is not a simple “pleasure fluid”. GABA and glutamate help regulate inhibition and excitation; serotonin, endocannabinoid and opioid systems affect perception, mood, pain, memory and many other functions. Different substances affect these systems differently.7
With repeated use, the brain adapts. Substance-related cues can acquire increasing motivational power; tolerance can reduce some effects; withdrawal or stress can intensify; habits become easier to trigger; alternative sources of reward can lose salience. This is plasticity - but plasticity does not automatically mean improvement. The same capacity that supports learning can also teach the brain to repeat an action compulsively.
Intoxication
The substance is actively affecting the brain. Subjective confidence can increase even as error monitoring, memory formation, coordination or risk assessment worsen. What feels like insight is not necessarily accurate insight.
Adaptation
Repeated exposure changes receptor, stress, habit and reward processes. More may be needed for the same effect - or the substance may be used simply to reduce discomfort and feel “normal” again.
Recovery
As exposure decreases, different systems readjust at different speeds. Sleep and concentration may initially worsen and improve later. Some cognitive and brain changes may recover substantially; others may persist.
Three claims that sound scientific - but are not enough on their own
- “It releases dopamine.” Food, music, novelty, learning and many medicines affect dopamine. Dose, timing, circuit and use pattern matter.
- “It increases neuroplasticity.” A greater capacity to change does not guarantee that the change will be beneficial, stable or wise. Experience and context shape the direction of learning.
- “The brain scan looks different.” A group-level brain-imaging difference alone does not prove dead neurons, lost IQ, causation or irreversibility.
Alcohol should be first in public understanding
It is common enough to seem ordinary, strong enough to erase memory formation, and socially widespread enough that people who do not drink themselves can still be harmed by other people’s drinking.
Society cannot claim to value intelligence while romanticising repeated impairment of cognitive functions. Honest education begins by naming ethanol accurately: a psychoactive substance, toxin and carcinogen - not a harmless category of beverage.
Decision quality weakens before a person realises it
Alcohol affects several systems, including GABA, glutamate, dopamine and endogenous opioids. Dose-dependent effects include weaker impulse control, slower reaction, impaired balance and speech, narrowed attention and poorer decisions. Feelings of relaxation or confidence do not restore these functions.
An alcohol blackout is failed memory formation
During an alcohol-related blackout, a person may be awake, talking and acting, yet fail to encode events into long-term memory because hippocampal memory processes are disrupted.8 This is not sleep, and behaviour that cannot be remembered is not harmless because of that.
Sedation is not restorative sleep
Alcohol disrupts sleep architecture: even the lower doses studied reduced REM sleep, while only higher doses shortened the time needed to fall asleep. Sedation is therefore not the same as restorative sleep.9
Repeated heavy exposure can affect cognitive functions through several pathways at once
Direct and adaptive effects on the brain
Long-term heavy use can alter neuronal structure, white matter, network efficiency and the balance of inhibitory, excitatory, reward and stress systems. On average, people with alcohol use disorder show difficulties with learning, memory, attention, information processing and executive functions, although individual profiles vary greatly.
Sleep, mood and motivation
Alcohol can become a quick route away from anxiety or stress while worsening sleep and intensifying negative emotions between use episodes. This cycle consumes exactly the abilities - planning, self-control and flexible problem-solving - needed to change it.10
Nutrition and thiamine
Severe alcohol use disorder can coexist with poor nutrition and impaired thiamine absorption. Wernicke-Korsakoff syndrome can cause confusion, coordination problems and very pronounced, sometimes permanent memory impairment. This is a medical condition - not a character flaw.11
Liver, blood vessels, trauma and oxygen
Liver disease, stroke, cardiovascular damage, falls, crashes, head injuries and episodes of reduced oxygen can each damage cognitive functions. The true burden on the brain is therefore much broader than the story of a single neurotransmitter.
Alcohol and cancer: “lower risk” is not “no risk”
Alcoholic beverages are causally linked to several types of cancer. Current evidence has not identified a threshold below which alcohol-related cancer risk disappears; risk generally increases as consumption increases. This does not mean that one sip guarantees disease. It means that there is no completely risk-free level from the perspective of cancer risk, and lower exposure is safer.435 The familiar idea that wine belongs in the category of “healthy” products does not erase the biology of ethanol and its metabolite acetaldehyde.
| Timescale | What may be affected | How it may appear in life | What not to overstate |
|---|---|---|---|
| During use | Inhibition, attention, coordination, reaction, memory encoding | Riskier decisions, missed details, conflicts, falls, unsafe driving, unremembered events | Effects depend on dose, speed of consumption, food, body, tolerance, medicines and other substances. |
| The next day | Sleep-dependent learning, alertness, mood, processing efficiency | Slower work, poorer learning, irritability, weaker error detection | Mild or absent hangovers do not prove that performance is normal. |
| Repeated heavy use | Executive control, learning, episodic memory, visuospatial abilities, processing speed | Unfulfilled plans, a narrowed daily life, forgotten commitments, slower acquisition of new skills | Not everyone develops the same deficit; observed results are affected by confounding factors. |
| Severe complications | Memory systems, coordination, general cognitive functions, consciousness | Wernicke-Korsakoff syndrome, stroke, traumatic brain injury, liver-disease-related encephalopathy | Some damage may persist, but early recognition and treatment can change the outcome. |
| Recovery | Attention, working memory, information processing, executive and memory functions | Clearer mornings, more reliable learning, better planning and greater everyday independence | Improvement is common, but complete recovery is not guaranteed and does not occur at the same speed for everyone. |
Alcohol does not need to cause a diagnosis to cost intellectual opportunities
Lost cognitive opportunities matter too. Hours spent intoxicated, fragmented sleep, blackouts, hangovers and recovery days are hours when memories form less reliably, practice accumulates more slowly and decisions have fewer chances to improve. Protecting intelligence means not only preventing dramatic damage - it also means preserving the ordinary repetitions from which mastery, wisdom and measured abilities grow.
Other substances must be compared carefully - not thrown into one frightening category
Medical use, supervised scientific research, repeated high-dose use and a street product of unknown composition are not equivalent exposures. Accurate comparison protects better than romanticising or indiscriminate demonisation.
| Substance or class | During intoxication | With repeated or heavy use | Distinctive severe risk | Recovery and evidence limits |
|---|---|---|---|---|
| Opioids | Drowsiness, narrowed attention, more difficulty concentrating or solving problems; in legitimate medicine - pain relief | Dependence, impaired motivation and moderate difficulties with attention, memory and executive functions - often alongside pain, poor sleep, mood and other substance effects | Respiratory depression; hypoxic brain injury or death in overdose, especially with a potent or contaminated product | Functioning can improve with stabilisation and treatment. Methadone or buprenorphine treatment is not equivalent to cycles of intoxication, withdrawal and overdose.17 |
| Benzodiazepines | Dose-dependent sedation, slower psychomotor performance, weaker attention and memory formation | Physical dependence can develop even when taken as prescribed; long-term cognitive studies are mostly observational, and a causal link with dementia has not been established | Dangerous sedation with alcohol or opioids; severe withdrawal when stopped too quickly after dependence has developed | The course of cognitive functions after careful tapering varies and is not fully characterised. Abrupt discontinuation in the presence of dependence can be dangerous.18 |
| Cocaine | Alertness and perceived energy alongside weaker impulse control, anxiety, panic or paranoia; stroke and seizures are possible | On average, long-term difficulties are found with sustained attention, response inhibition, memory, reward learning and decision-making | Cardiovascular or neurological crisis; some illicit products may contain fentanyl | Recovery is possible, but its course is difficult to separate from sleep, other substance use, mental health and vascular or neurological injury.15 |
| Methamphetamine | Alertness and energy can coexist with impulsivity, anxiety, paranoia, sleep deprivation and distorted confidence | Average descriptions include difficulties with memory, processing, executive, motor and other cognitive functions | Stroke, arrhythmia, overheating, severe psychiatric symptoms and overdose - including polysubstance overdose | Recovery may occur, but cognitive functions and their time course vary and are not fully characterised.14 |
| Cannabis / THC | Altered sense of time and perception; impaired attention, working memory, learning, coordination and driving ability | Greatest concern is associated with early initiation, frequent use and high THC content; causal estimates are complicated by mental health, family and educational factors | Panic, risk of psychosis in vulnerable people, injuries while intoxicated; high-potency and edible products can be less predictable | Acute impairment is well established. A fixed number of inevitably “lost IQ points” is not.1333 |
| Nicotine / tobacco | Nicotine changes arousal and can cause dependence; subjective stimulation does not prove long-term cognitive enhancement | Dependence sustains exposure. Combustion causes enormous cancer, lung and vascular harm; vascular disease threatens brain health | Cardiovascular disease, stroke, cancer and severe respiratory disease | Stopping smoking protects vascular and overall health. Short-term stimulation does not make smoking a safe cognitive enhancer.19 |
| Classic psychedelics | Altered perception and experience of time, self and thoughts; acute attention, working memory and reaction impairments can occur even when “insight” is felt | Dependence potential is generally lower than for alcohol, nicotine or opioids, but long-term cognitive functions and unsupervised use patterns are less well characterised | Panic, confusion, dangerous behaviour while intoxicated and rare persistent psychiatric or perceptual disturbances; risk is higher with certain psychiatric vulnerabilities | Clinical trials use screening, known doses, support and monitoring. Long-term IQ enhancement and reliable cognitive improvement have not been established.20 |
| MDMA | Stimulant and empathy-enhancing effects alongside physiological strain; attention or memory difficulties may occur | Regular use is associated with sleep, mood, memory and attention problems, but polysubstance use and uncertain product composition complicate causal attribution | Dangerous overheating, cardiovascular stress and adulterated tablets or powders | Pharmaceutical MDMA research cannot be generalised to “ecstasy” or “molly” products of unknown composition.36 |
| Ketamine | Dissociation, sedation, amnesia, impaired coordination and acute cognitive difficulties; legitimate anaesthetic and supervised psychiatric use exists | Frequent heavy recreational use is associated with memory, executive-function and urinary-tract damage | Loss of consciousness, injuries and dangerous combinations with depressant substances; uncertain dose or contaminants | Cognitive recovery after stopping heavy use cannot be assigned to one reliable timetable. Supervised medical care is not the same as unsupervised repeated use.21 |
Feeling faster does not mean becoming smarter
Stimulants can increase alertness, confidence or speed on some simple tasks while worsening sleep, accuracy of self-assessment, impulse control and complex decisions. Subjective “sharpness” is not an IQ test and does not prove better learning.
Feeling that an experience is deep is not confirmed insight
A psychedelic experience can feel highly meaningful. Personal meaning may matter, but strong conviction during altered consciousness does not confirm the truth of the thought itself. “Neuroplastic” is not a synonym for “intelligent”, “therapeutic” or “safe”.
Prescription does not mean risk-free - but context matters
A known medicine, appropriate dose, medical indication and monitoring can completely change the balance of benefit and risk. This does not make misuse safe and does not justify equating effective treatment with uncontrolled illicit supply.
Why long-term cognitive studies need careful interpretation
People are not randomly assigned to use psychoactive substances heavily for years. Trauma, poverty, chronic pain, mental illness, sleep, nutrition, education, head injuries, prenatal factors, baseline cognitive level and polysubstance use can affect both exposure and later outcomes. Researchers adjust for measured confounders, compare twins, follow people over time and combine different methods - but uncertainty remains. The honest conclusion is neither “we know nothing” nor “every association proves permanent brain damage”.
Dose, developmental stage, sleep and combinations can completely change the danger
The substance name is only the beginning. Risk often increases because of concentration, repetition, rapid delivery, combined use, unsafe circumstances and uncertainty about what is actually in the product.
Dose and potency
Greater exposure generally increases impairment and poisoning risk. Modern concentrates, high-THC products, counterfeit pills and potent synthetic opioids can make previous experience with weaker products dangerously misleading.
Speed of delivery
Rapid delivery to the brain generally creates a sharper effect and can strengthen reward reinforcement. The route of use also changes infection, lung, tissue and overdose risks. No route of use makes an intoxicating substance cognitively neutral.
Age and development
Adolescence is a period of intense learning and neural-network reorganisation. Earlier initiation is associated with greater later disorder risk, while effects on learning, sleep and social learning can accumulate over many years.22
Frequency and recovery time
Repeated exposure can prevent sleep, mood, attention and physiology from returning to baseline. Even heavy episodes limited to weekends can be dangerous; daily “small” use can still create cumulative exposure and dependence.
Health and medicines
Heart, liver, lung, seizure, pain and mental health conditions can change risk. Prescription and over-the-counter medicines and supplements can interact even when each is legal on its own.
Environment
Driving, swimming, height, cold, heat, conflict, isolation and access to help change the consequences. The same blood concentration can have entirely different consequences while sitting on a sofa and driving a car.
Combinations can add, multiply or conceal risk
| Combination | What can happen | Misleading sense of safety to reject | Protective principle |
|---|---|---|---|
| Alcohol + opioids | Sedation and respiratory depression can intensify, increasing the risk of loss of consciousness, brain hypoxia and death. | “They are different substances, so they balance each other out.” | Avoid the combination; where opioids may be present, naloxone provides an additional life-saving layer of protection but does not make use safe.23 |
| Alcohol + benzodiazepines or other sedatives | Risk increases for memory impairment, falls, aspiration, respiratory depression and dangerous loss of consciousness. | “Both are legal or prescribed by a doctor, so the combination is medically safe.” | Do not combine them without clear advice from a doctor or pharmacist.24 |
| Stimulants + alcohol | A person may feel less sleepy without being less intoxicated; cardiovascular strain may increase and alcohol use may continue for longer. | “If I feel alert, I must be sober.” | Alertness does not restore decision-making or coordination and does not speed alcohol elimination. |
| Alcohol + cannabis | Coordination, attention, reaction and driving ability may be more impaired than with either substance alone. | “The amount of each substance is small, so the combined effect will also be small.” | Do not drive or operate machinery; subjective assessment of a mixture’s effects is unreliable. |
| Products of unknown origin | There may be unexpected potency, fentanyl, xylazine, synthetic cannabinoids or another active substance. | “It looks the same as a product I used before.” | Appearance and a seller’s claims do not confirm composition; where available, drug-checking and harm-reduction services can reduce uncertainty. |
Know what naloxone can - and cannot - reverse
Naloxone can temporarily reverse the effects of an opioid overdose; it does not reverse alcohol or benzodiazepine poisoning. If an opioid overdose is suspected, use naloxone if available, call emergency services and stay with the person. Opioid effects can return after naloxone wears off, so urgent medical assessment is still needed.23
If physical dependence may have developed, plan withdrawal safely
If alcohol use has been heavy, long-term or previously caused withdrawal symptoms, suddenly stopping at home may be unsafe. For some people, alcohol withdrawal can cause seizures or delirium. Benzodiazepines should also not be stopped suddenly after dependence has developed; a slow, individualised taper may be needed.2518 This is a reason to create a medical plan - not a reason to delay change. Seizures, hallucinations, severe confusion or delirium, as well as inability to remain conscious, require urgent medical assessment.
When a substance begins to take away cognitive freedom
The problem is not defined by quantity alone. The clearest signal is often a changing relationship between use, control, consequences and the life a person actually wants.
Blackouts, unremembered conversations or unexplained gaps appear - even if others say the person seemed alert at the time.
Memory, concentration or learning speed declines, or ordinary tasks require more checking and recovery time.
More is needed for the same effect, or use begins earlier, happens faster or lasts longer than planned.
The substance becomes the default tool for sleep, anxiety, boredom, pain, celebration, confidence or simply feeling normal.
Plans to reduce use repeatedly dissolve, despite sincere intentions and repeated evidence of harm.
Work, studies, money, relationships or safety begin to pay the cost, while explanations become increasingly complicated.
Withdrawal or rebound appears: shaking, sweating, insomnia, agitation, nausea, anxiety or the need to use again simply to reduce discomfort.
Trusted people notice a change in reliability, personality, decisions, alertness or being “present”.
Recognition is information - not a verdict
People use substances for understandable reasons: relief, connection, trauma, pain, exhaustion, curiosity, habit or pleasure. Acknowledging the function does not deny the harm. It shows what successful change will need to replace. If alcohol is the only available route to sleep or social ease, removing it without creating another route leaves the original need in place.
Ask about the function
“What does it give me immediately?” “What does it cost me tomorrow?” “In what situations does use become automatic?” “What need would remain if I stopped using?” These questions reveal the learning loop better than self-criticism.
Ask about the direction
“Is my world getting bigger or smaller?” “Am I learning faster or spending longer recovering?” “Do my decisions still match my values?” Cognitive freedom is not only the ability to refuse - it is the ability to choose from real alternatives.
The brain can recover - and recovery runs on several different clocks
Intoxication may pass within hours; sleep, mood and attention may change over days or weeks; learning, executive functions and brain systems may continue changing for months or longer.
Recovery means usable abilities returning
Clearer mornings, reliable memory, returning curiosity, steadier attention and the ability to finish a plan are not small results. They are the infrastructure of everyday intelligence. Many people recover substantially, and this growth deserves to be noticed and celebrated.
First: stabilise
Safely remove the risk of direct intoxication and repeated poisoning; treat withdrawal when needed; restore food, fluids, the opportunity to sleep and medical stability. Concentration may fluctuate early on.
Then: restore
Practise routines, attention, memory strategies and new reward pathways. Treat pain, trauma, ADHD, anxiety, depression or sleep disorders that would otherwise keep the old use cycle useful.
Over time: expand
Return to education, demanding work, physical activity, relationships and creative projects. Repeated successful learning becomes evidence that the future is larger than the previous pattern.
What the evidence shows about cognitive recovery after alcohol use disorder
Sixteen small and heterogeneous longitudinal studies of abstinent people aged 18–64 with alcohol use disorder found that most initially impaired functions reached comparison-group or normative levels in approximately six to twelve months. Some processing-speed and working-memory changes appeared earlier; planning, flexibility, reasoning and some memory outcomes were less consistent or took longer.12
These intervals are not a personal countdown. Studies were small and heterogeneous, and people differed in age, duration of exposure, nutrition, smoking, liver disease, head injuries, other substance use, mental health and confirmed abstinence duration. Improvement is common; complete recovery cannot be promised. Persistent difficulties deserve assessment because they may be treatable, compensable or due to an entirely different cause.
Sleep and rhythm
A regular wake time, sufficient opportunity for sleep and treatment for insomnia or sleep apnoea reduce cognitive noise. Sleep may temporarily worsen during withdrawal; that does not mean the substance was creating healthy sleep.
Nutrition and medicine
Adequate food matters, but suspected thiamine deficiency or Wernicke encephalopathy requires medical treatment - not a commercial “brain supplement stack”. Assess liver, heart, neurological and medication factors.
Movement and challenge
Gradually restoring physical activity, learning and meaningful tasks can support health and confidence in cognitive abilities. These are valuable additions - not substitutes for withdrawal treatment, medication or therapy.
External memory
Calendars, checklists, consistent places for belongings and written plans reduce load while memory recovers. Compensation is intelligent system design, not surrender.
Low-friction environment
Remove cues, add alcohol-free alternatives, plan the hardest time in advance and make the safer action easier. Willpower fluctuates; the environment can help a decision remain stable.
People who support the goal
Recovery may be easier to sustain when reduced use, abstinence and medication are not mocked. Connection can provide accountability without surveillance and care without shame.
Returning to use is information, not a final verdict. It may mean that treatment intensity, medication, environment or support needs to change. The next useful decision matters more than shame.31
Evidence-based treatment is not one programme and is not one ideology
Effective care may combine medication, behavioural therapy, peer support, medical monitoring and environmental change. Detoxification is a beginning - not the entire treatment plan.
| Condition or substance | Evidence-based options | What to know |
|---|---|---|
| Alcohol use disorder | Behavioural therapy; oral or extended-release naltrexone; acamprosate; disulfiram in selected cases; mutual-help options | For many adults, naltrexone and acamprosate have the clearest medication evidence. Choice depends on goals, liver or kidney health, opioid use, pregnancy, treatment adherence and other factors.26 |
| Opioid use disorder | Methadone or buprenorphine; extended-release naltrexone for selected people; behavioural and practical support | Methadone and buprenorphine reduce cravings, withdrawal, overdose and mortality. This is treatment - not “replacing one addiction with another”. Extended-release naltrexone requires a specialist-supervised opioid-free period before starting; starting too early can precipitate withdrawal. Continuity of treatment matters.17 |
| Stimulant use disorder | Contingency management; cognitive behavioural therapy, community reinforcement and other structured methods | Contingency management is currently considered the standard of care. It uses reliable rewards to strengthen specific recovery-supporting behaviour. The FDA has not currently approved a medication specifically for stimulant use disorder.27 |
| Cannabis use disorder | Cognitive behavioural therapy, motivational enhancement and contingency management | The FDA has not currently approved a medication specifically for cannabis use disorder or withdrawal; sleep and mood support may be part of care. |
| Benzodiazepine dependence | Individualised, clinician-supervised tapering when the risks of continued use outweigh the benefits; treatment of the original anxiety, sleep or other condition | Physical dependence is an adaptation process and can develop even when taken as prescribed. Abrupt discontinuation can be dangerous. |
| Nicotine dependence | Behavioural support combined with approved stop-smoking medicines such as nicotine replacement therapy, varenicline or bupropion when appropriate | For many people, combining counselling and medication increases the chance of success. Temporary withdrawal-related worsening of attention is expected and treatable. |
Good care asks what problem the substance was solving
Pain, panic, insomnia, trauma, loneliness, boredom, untreated ADHD and social pressure do not disappear after detoxification. Treating the function of use is part of treating the disorder.
Medication can protect cognitive functions
Stabilising physiology, protecting against withdrawal and overdose and reducing cravings can create the reliable attention and time needed for learning. Treatment without medication is not automatically safer or “more recovered”.
Peer support can take many forms
Twelve-step, secular, culturally adapted, professionally led and other mutual-help communities can help. Fit matters; one unsuitable group does not mean all support is useless.
How to assess a treatment service
- Licensed professionals work there, and qualifications, privacy, cost and evidence are explained clearly.
- Withdrawal, overdose, mental health, pain, sleep, medication, cognitive and physical-health risks are assessed.
- When appropriate and available, evidence-based medicines are offered or coordinated instead of requiring a “medication-free” ideology.
- An individual plan is created and meaningful outcomes are assessed - not only attendance or “correct” language.
- Setbacks or return to use are treated as reasons to adjust care, not to humiliate or expel the person.
- There are no guaranteed cures, fixed brain “recovery” timelines or expensive miracle detoxes.
Intelligence and IQ growth deserve support and celebration
Protecting the mind is not only a defensive project. The goal is greater ability to learn, reason, create, navigate life and turn knowledge into better decisions.
Every hour of clear attention can become part of a larger mind. Skills accumulate. Knowledge reshapes reasoning. Better decisions protect the next opportunity to learn.
IQ tests approximately assess selected cognitive abilities under defined conditions; they do not measure a person’s dignity and do not include every form of intelligence. But measured abilities matter. Reasoning, working memory, processing efficiency and accumulated knowledge affect how quickly a person learns, solves problems and considers consequences. It is entirely reasonable to value growth in these abilities without turning one score into a hierarchy of human worth.
Reducing psychoactive-substance use does not guarantee a fixed IQ increase, and one drink does not erase a permanent number of points. But a stronger claim is important enough: by reducing intoxication, blackouts, sleep disruption and repeated recovery time, existing abilities may function more reliably; recovery may improve affected cognitive functions; and long-term education and demanding learning can produce real, measurable gains. A large quasi-experimental meta-analysis estimated a benefit of roughly one to five IQ points from one additional year of education.32
| Level | Goal | What it may look like | What is worth celebrating |
|---|---|---|---|
| Protect | Reduce avoidable impairment and injuries | Fewer hours intoxicated, no driving while impaired, safer medication use, protected sleep, later initiation of use among adolescents | A clear decision made before pressure changes it |
| Restore | Regain functions and compensate intelligently | Treatment, stable routine, memory aids, nutrition, sleep care, gradual return to demanding tasks | Reliable mornings, remembered conversations and completed plans |
| Grow | Build new reasoning, knowledge and mastery | Education, deliberate practice, reading, problem-solving, creative work, feedback and teaching others | Skills that once seemed impossible become ordinary |
Use spaced and effortful learning
Retrieval practice, feedback and learning distributed over time build more durable knowledge than repeated rereading while intoxicated or exhausted. Protect time when the brain can encode and consolidate well.
Choose gradually increasing challenges
Move from reliably completed tasks to those requiring new strategies. Cognitive growth comes from long-term adaptation - not chasing a chemical feeling of genius.
Let other minds strengthen progress
Teachers, peers and communities can provide feedback, examples, tools and opportunities. An individual mind protected from harm grows further when its social environment welcomes curiosity and celebrates improvement.
Celebrate clarity without demanding perfection
An alcohol-free event, the first sincere conversation, carefully following a tapering plan, a month of treatment, returning to a term, a new qualification, repaired relationships and a better test result can all be real milestones. Recovery and intellectual growth are not competing stories. Recovery can reopen the conditions in which intelligence grows.
Why public perceptions of risk can become inverted
No secret plan is required. Familiarity, social rituals, commercial interests, policy history and selective attention can turn a substance that causes a heavy burden into an apparently harmless default choice.
What is common begins to look safe
When a substance is constantly visible at family meals, in supermarkets, sport and celebrations, repetition itself becomes proof of normality to the mind - even though prevalence says nothing about toxicology.
Law is mistaken for medical endorsement
Psychoactive-substance laws reflect history, culture, law enforcement, politics and commerce, as well as harm. A 2010 United Kingdom analysis found that legal classification correlated poorly with expert harm scores.1
The product borrows the image of a life
Advertising links alcohol with confidence, adulthood, romance, success and belonging. Longitudinal studies of young people cannot remove every confounder, but greater marketing exposure has repeatedly been associated with later initiation and heavier use.28
Celebration becomes conditional
Phrases such as “a normal toast”, “a real party” or “you have to have at least one” make abstinence seem antisocial. The cultural script hides the psychoactive substance inside tests of belonging.
Acute tragedies from illicit substances take all the attention
Dramatic overdose is rightly horrifying. Alcohol’s burden is often slower and dispersed across cancer, cardiovascular disease, injuries, family harm and millions of everyday episodes, so no single image captures it.
Revenue and health goals can conflict
Manufacturers profit from sales; governments collect taxes; families, workplaces and health systems absorb some of the harm. These circumstances create incentives that require transparency and independent policy - not the assumption that revenue proves safety.
Commercial conflicts of interest can be measured without conspiracy claims
An analysis for England estimated that people drinking above the national low-risk guideline accounted for about 68% of alcohol sales revenue, while the heaviest-drinking 4% accounted for 23%.29 This does not prove that every company seeks dependence. It shows a structural conflict: a major reduction in harmful use can also mean a major reduction in sales.
WHO continues to report interference by the alcohol industry in policymaking and urges assessment of potential conflicts of interest.35 Researchers have documented lobbying, selective use of evidence, partnerships and movement of people between the public and industry sectors.30 The responsible conclusion is not that every official is corrupt. It is that product regulation should rely on transparent and independent evidence.
Tax revenue is not a biological safety signal - or the whole balance sheet
Alcohol excise duties generate public revenue, but governments also cover the costs of disease, crashes, violence, treatment, law enforcement and lost productivity. Well-designed excise duties can reduce harmful use while generating revenue.6 Collecting tax does not require encouraging consumption and does not turn ethanol into a health product.
Was the 2010 alcohol ranking merely one group’s opinion?
It was a structured expert model, not a perfect universal measure. The weights incorporated judgement, harm depended on the United Kingdom’s consumption and policy context, and the model did not fully capture route of use, pattern, polysubstance use or all consequences of prohibition. These limitations should be presented alongside the main conclusion. However, in later multicriteria assessments by European experts and in Aotearoa New Zealand, alcohol also ranked first for overall harm, although the order below it varied by context.16 The repeated lesson is not that every score is eternal; it is that alcohol’s legal normality conceals a very large overall burden.
Families, communities and policy can make clear choices easier
Education matters, but information cannot fairly compete with constant availability, persuasive advertising, low prices and social pressure if the environment itself does not change.
Make the next choice concrete
- Know the reason for use and plan an alternative.
- Decide on boundaries before intoxication changes decisions.
- Protect driving, sleep, study and medication use.
- Choose a reduction or abstinence goal according to actual risk.
- Seek qualified help if control or withdrawal problems arise.
Make non-use socially normal
- Offer appealing alcohol-free choices without comment.
- Never demand an explanation for why someone does not drink.
- Celebrate recovery, medication treatment and cognitive progress.
- Talk about observed effects, not “flaws” in character.
- Set clear boundaries around violence, driving and children’s safety.
Make the environment fair
- Clear health information and accurate labelling.
- Limits on advertising, sponsorship and youth exposure.
- Evidence-based pricing and availability rules.
- Prevention and enforcement against impaired driving.
- Accessible treatment, naloxone and harm reduction.
How to speak with someone without helping the problem hide
| Less useful | More useful | Why |
|---|---|---|
| “You are ruining everything.” | “This month you forgot three plans after drinking, and I’m worried about your memory and safety.” | Concrete observations are harder to deny and do not define the whole person. |
| “Just have more willpower.” | “What time, feeling or place makes stopping hardest, and what could we change before it happens?” | Moral judgement becomes a solvable pattern. |
| “Treatment means you failed.” | “Effective treatment is a way to protect your brain, choices and future.” | Help is linked with ability and dignity. |
| “I’ll cover for you again.” | “I care about you, but I won’t provide a car, money or an excuse that makes unsafe use easier.” | Support and boundaries can coexist. |
Population protection already has an evidence-based roadmap
WHO’s SAFER initiative prioritises restrictions on availability; measures against drink-driving; access to screening, brief intervention and treatment; comprehensive restrictions on advertising, sponsorship and promotion; and pricing policies, including excise duties.6 This is not punishment for pleasure. It is a response to a product whose cost also falls on people who did not choose the exposure themselves.
Common myths - and corrections that protect the mind
The goal is neither panic nor permission. The goal is one consistent evidence standard.
| Myth | Evidence-based correction |
|---|---|
| “Alcohol is not really a psychoactive substance.” | Ethanol is psychoactive, toxic and dependence-producing. Beverage branding does not create a separate biological category. |
| “Legality means it is safer.” | Legal status is a policy classification. It is not a ranking of toxicity, dependence, cognitive impairment or social harm. |
| “A score of 72 means alcohol is always worse than heroin.” | The score combined 16 harm criteria in the 2010 United Kingdom context. Heroin and crack scored higher for harm to the user; alcohol ranked first overall because of especially high harm to others. |
| “Wine is healthy, so the alcohol in it does not count.” | Ethanol is the same causal carcinogen in wine, beer and spirits. Possible non-alcohol components do not erase alcohol-attributable risk. |
| “Coffee, a cold shower or a stimulant sobers you up.” | A greater feeling of alertness does not speed alcohol elimination or restore coordination, memory or decision quality. |
| “If there was no blackout, the brain was not harmed.” | Impairment begins well before the level that produces memory loss. Memory gaps are one severe sign - not a threshold for harm. |
| “Natural means safe.” | Origin does not tell you the dose, receptor effects, contamination, poisoning risk or psychological impact. |
| “Psychedelic neuroplasticity means higher IQ.” | Plasticity means the capacity to change, not the direction or value of change. Reliable and lasting IQ increases have not been established. |
| “Medication for opioid use disorder is just another addiction.” | Prescribed methadone and buprenorphine stabilise receptor activity, reduce withdrawal and cravings, help people remain in treatment and reduce mortality. |
| “Dependence proves weak character.” | Psychoactive-substance use disorders arise from interacting biology, learning, development, environment and opportunity. Responsibility for the next step can coexist with compassion. |
| “Brain damage is always irreversible.” | Many cognitive functions and brain measures improve as recovery continues, although severe injuries may persist and one precise timeline does not fit everyone. |
| “One relapse erases all progress.” | Skills, knowledge and previous recovery remain. Relapse is information for adjusting the plan, not proof that change is impossible. |
Clear minds need a culture that tells the truth
No intoxicating or potentially dependence-producing substance discussed here is completely risk-free. Their harms are not identical, and laws do not rank them scientifically. Alcohol’s normality should never conceal its ability to disrupt memory and decisions, cause dependence and cancer, and harm other people. Correcting myths about alcohol should not lead us to minimise the dangers of illicit substances.
Protecting intelligence means applying the same standard to every substance: name the chemistry accurately, compare the full evidence base, reduce exposure, protect developing brains, ensure access to treatment and celebrate returning attention, memory, learning and autonomy. A safer culture does not shame people for needing help. It makes clarity easier to choose - and growth easier to sustain.
Estudos primários, orientações clínicas e fontes de saúde pública
A classificação comparativa é apresentada juntamente com o respetivo âmbito de aplicação e limitações. As afirmações clínicas baseiam-se principalmente em orientações oficiais, revisões sistemáticas e estudos primários. As datas de publicação e as notas sobre as fontes estão incluídas para que o leitor possa distinguir uma estimativa mundial atual de um modelo histórico ou de um estudo específico de determinado contexto.
Danos das drogas no Reino Unido
Nutt, King e Phillips, 2010 · Análise multicritério de 20 substâncias psicoativas publicada na Lancet, com base em 16 critérios de danos ponderados. Modelo especializado para um contexto específico; não é uma tabela de risco por dose única.
Ver no PubMed ↗Relatório sobre a situação mundial do tratamento do álcool e das drogas
Organização Mundial da Saúde, 2024 · O mais recente relatório mundial da OMS, que utiliza estimativas de mortalidade e incapacidade relativas a 2019.
Ler o relatório da OMS ↗Álcool: riscos para a saúde e impacto
Organização Mundial da Saúde, 2024 · O etanol é definido como uma substância psicoativa, tóxica e que causa dependência; são resumidas as doenças, lesões, consequências para terceiros e medidas políticas.
Ler a ficha informativa da OMS ↗Não existe um limiar sem risco para o cancro atribuível ao álcool
OMS Europa, 2023 · Explica as evidências da relação dose-resposta e por que razão não foi identificado um limiar de risco de cancro abaixo do qual o risco desapareça.
Ler a declaração da OMS ↗Determinantes comerciais das doenças não transmissíveis
OMS Europa, 2024 · Relatório sobre a forma como os produtos comerciais, as práticas empresariais e a influência política contribuem para a carga de doença.
Ler o relatório da OMS Europa ↗Iniciativa SAFER de controlo do álcool
Organização Mundial da Saúde · Cinco áreas de política de grande impacto: disponibilidade, condução, tratamento, marketing e preços.
Explorar o SAFER da OMS ↗Drogas e o cérebro
Instituto Nacional dos EUA sobre o Abuso de Drogas · Revisão científica acessível da sinalização neuronal, da recompensa, dos hábitos e dos sistemas cerebrais envolvidos na dependência.
Ler a análise do NIDA ↗Álcool e o cérebro
Instituto Nacional dos EUA sobre o Abuso de Álcool e o Alcoolismo · Revisão da memória, tomada de decisões, coordenação, apagões alcoólicos e efeitos a longo prazo no cérebro.
Ler a análise da NIAAA ↗Álcool e sono subsequente
Gardiner et al., 2025 · Revisão sistemática e meta-análise dos efeitos da dose e do momento do consumo na arquitetura objetiva do sono.
Ver no PubMed ↗O ciclo da dependência do álcool
NIAAA · Modelo científico do ciclo de consumo excessivo/intoxicação, abstinência/estado emocional negativo e preocupação/antecipação.
Ler a explicação do NIAAA ↗Síndrome de Wernicke-Korsakoff
NIAAA · Deficiência de tiamina, perturbação grave do consumo de álcool, sintomas, riscos e possível perda de memória a longo prazo.
Ler a ficha informativa do NIAAA ↗Recuperação cognitiva após a abstinência de álcool
Powell et al., 2024 · Revisão sistemática de 16 estudos longitudinais; a recuperação variou consoante o domínio cognitivo e a qualidade dos estudos.
Ler a análise aberta ↗Canábis e saúde
Instituto Nacional dos EUA sobre o Abuso de Drogas, atualizado em 2024 · THC, efeitos agudos, potência, cérebro em desenvolvimento, saúde mental e investigação sobre tratamentos.
Ler a página temática do NIDA ↗Metanfetamina
National Institute on Drug Abuse dos EUA, atualizada em 2024 · Efeitos agudos, problemas de memória e de saúde a longo prazo, sobredosagem e tratamento comportamental.
Ler a página temática do NIDA ↗Cocaína
National Institute on Drug Abuse dos EUA · Riscos neurológicos, cardiovasculares e cognitivos, produtos contaminados e evidências relativas ao tratamento.
Ler a página temática do NIDA ↗Replicações de comparações de danos
Avaliação de especialistas europeus, 2015, e avaliação de Aotearoa Nova Zelândia, 2023 · Ambos avaliaram o álcool como o produto que causava o maior dano global, embora outros locais diferissem consoante o contexto.
Estudo europeu ↗ · Estudo da Nova Zelândia ↗Medicamentos para a perturbação do consumo de opioides
National Institute on Drug Abuse dos EUA, atualizado em 2025 · Metadona, buprenorfina e naltrexona; continuidade do tratamento, sobredosagem e mortalidade.
Ler as orientações do NIDA ↗Aviso destacado sobre benzodiazepinas
Food and Drug Administration dos EUA · Uso indevido, dependência, interações e abstinência potencialmente fatal após uma redução súbita ou demasiado rápida da dose.
Ler a comunicação da FDA ↗Tabaco
Organização Mundial da Saúde · Dependência, doenças cardiovasculares, acidente vascular cerebral, cancro, exposição passiva e carga global.
Ler a ficha informativa da OMS ↗Drogas psicadélicas e dissociativas
National Institute on Drug Abuse dos EUA · Alterações agudas da consciência, riscos e diferença entre um estudo terapêutico supervisionado e o consumo não supervisionado.
Ler a página temática do NIDA ↗Cetamina
National Institute on Drug Abuse dos EUA · Dissociação, memória e coordenação, uso médico, danos do consumo repetido e dependência.
Ler a página temática do NIDA ↗O cérebro dos adolescentes e o consumo de substâncias
National Institute on Drug Abuse dos EUA, 2024 · Desenvolvimento, exposição precoce e risco posterior de perturbação do consumo de substâncias psicoativas.
Ler a análise do NIDA ↗Naloxona e reversão da sobredosagem de opioides
Centros de Controlo e Prevenção de Doenças dos EUA · O que faz a naloxona, quem pode tê-la e por que razão o acompanhamento médico posterior continua a ser importante.
Ler as orientações do CDC ↗Interações entre álcool e medicamentos
NIAAA · Mecanismos e riscos da combinação de álcool com opioides, benzodiazepinas e outros medicamentos.
Ler a análise da NIAAA ↗Gestão da abstinência alcoólica
American Society of Addiction Medicine, 2020 · Avaliação do risco, contexto do tratamento e o princípio de que a gestão da abstinência, por si só, não é tratamento da perturbação do consumo de álcool.
Ler as orientações da ASAM ↗Tratamento do alcoolismo baseado em evidências
NIAAA, atualizada em 2025 · Tratamento comportamental e opções farmacológicas; incluindo naltrexona, acamprosato e, em casos selecionados, dissulfiram.
Ler as orientações da NIAAA ↗Orientação sobre a perturbação do consumo de estimulantes
ASAM e AAAP, 2024 · Orientações clínicas que identificam a gestão de contingências como o padrão atual de cuidados.
Ler as orientações abertas ↗Publicidade ao álcool e consumo posterior entre jovens
Tanski et al., 2015, e de Bruijn et al., 2016 · Estudos longitudinais; as associações ajustadas não eliminam todos os possíveis fatores não medidos.
Estudo dos EUA ↗ · Estudo europeu ↗Receitas de vendas e consumo mais elevado
Bhattacharya et al., 2018 · Modelo específico para Inglaterra que estima a proporção das receitas das vendas de álcool proveniente do consumo acima das recomendações nacionais.
Ver no PubMed ↗Envolvimento da indústria do álcool nas políticas
McCambridge, Mialon e Hawkins, 2018 · Revisão sistemática de estudos documentais e de entrevistas; o contexto e a quantidade de dados disponíveis variam.
Ler a análise aberta ↗Tratamento e recuperação
National Institute on Drug Abuse dos EUA · Princípios do acompanhamento contínuo e explicação de por que razão o regresso ao consumo pode significar um ajustamento do tratamento, e não uma censura.
Ler a análise do NIDA ↗Educação e inteligência medida
Ritchie e Tucker-Drob, 2018 · Metanálise de 42 conjuntos de dados e mais de 600 000 participantes, utilizando desenhos quase experimentais.
Ver no PubMed ↗Canábis e QI: uma análise com gémeos
Jackson et al., 2016 · Os gémeos que consumiam canábis não apresentaram uma diminuição do QI superior à dos gémeos que não consumiam, ilustrando a importância dos fatores de confusão familiares.
Ler o estudo da PNAS ↗Carga global dos fatores de risco
Colaboradores do GBD 2021 Risk Factors, 2024 · Análise comparativa global dos riscos; a carga populacional não corresponde ao risco de uma dose individual.
Ler a análise aberta da Lancet ↗Carga global do cancro atribuível ao álcool
Rumgay et al., 2021 · Estudo de modelização liderado pela IARC que avalia os novos casos de cancro em 2020 atribuíveis ao álcool.
Ver no PubMed ↗MDMA (Ecstasy/Molly)
National Institute on Drug Abuse dos EUA, atualizado em 2024 · Efeitos, riscos para a saúde, contaminação e diferença entre produtos ilegais e investigação científica supervisionada.
Ler a análise do NIDA ↗Nota educativa e de avaliação: este artigo apresenta informações gerais, não um diagnóstico nem aconselhamento médico, psiquiátrico, jurídico ou individualizado sobre o consumo de medicamentos. Os efeitos das substâncias psicoativas e as necessidades de tratamento variam consoante a substância, o produto, a dose, o padrão de consumo, a idade, a gravidez, o estado de saúde, os medicamentos sujeitos a receita médica e a composição local de produtos ilegais. Não inicie, interrompa nem reduza rapidamente um medicamento sujeito a receita médica ou um preparado que possa causar dependência sem supervisão clínica adequada. A abstinência, especialmente de álcool e benzodiazepinas, pode exigir um plano médico.